hydrochlorothiazide has been researched along with spirapril in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HS; Baum, T; Coleman, W; Nelson, S; Pula, KK; Rivelli, M; Sabin, C; Sybertz, EJ; Tedesco, R; Watkins, RW | 1 |
| Drabaek, H; Gleerup, G; Mehlsen, J; Petersen, JR; Petersen, LJ; Winther, K | 1 |
| Gleerup, G; Mehlsen, J; Petersen, JR; Winther, K | 1 |
| Hietanen, EK; Kantola, IM; Kataja, MJ; Pelttari, LH; Salo, TT | 1 |
| Kantola, I; Pelttari, L; Salo, TM; Viikari, JS; Voipio-Pulkki, LM | 1 |
| Armini, L; Bardelli, M; Calci, M; Campanacci, L; Candido, R; Carretta, R; Fabris, B; Fazio, M; Fischetti, F | 1 |
| Amschler, S; Erb, K; Hermann, R; Junge, K; Krupp, S; Schäfer, HF; Schulz, HU; Schürer, M | 1 |
5 trial(s) available for hydrochlorothiazide and spirapril
| Article | Year |
|---|---|
ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cardiography, Impedance; Cross-Over Studies; Diastole; Double-Blind Method; Echocardiography; Enalapril; Female; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Myocardial Contraction; Rest; Stroke Volume; Vascular Resistance; Vasodilation; Ventricular Function, Left | 1996 |
Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension.
Topics: Aged; Alpha-Globulins; Angiotensin-Converting Enzyme Inhibitors; Blood Platelets; Diuretics; Double-Blind Method; Enalapril; Epinephrine; Exercise; Fibrinolysis; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Sodium Chloride Symporter Inhibitors | 1996 |
Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Circadian Rhythm; Diuretics; Double-Blind Method; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Middle Aged; Sleep Apnea Syndromes; Sodium Chloride Symporter Inhibitors; Treatment Failure | 1998 |
The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients--assessment by spectral analysis of heart rate and blood pressure variability.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Autonomic Nervous System; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Enalapril; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Isradipine; Male; Middle Aged; Sleep Apnea Syndromes; Sodium Chloride Symporter Inhibitors | 1999 |
Drug interaction of spirapril hydrochloride monohydrate and hydrochlorothiazide. A clinical study to compare the pharmacokinetics after administration of spirapril hydrochloride monohydrate tablets, hydrochlorothiazide tablets and fixed combination bi-lay
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Area Under Curve; Biological Availability; Diuretics; Drug Combinations; Drug Interactions; Enalapril; Half-Life; Humans; Hydrochlorothiazide; Male; Single-Blind Method; Sodium Chloride Symporter Inhibitors; Tablets | 2003 |
2 other study(ies) available for hydrochlorothiazide and spirapril
| Article | Year |
|---|---|
Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
Topics: Adrenergic Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dogs; Enalapril; Female; Hemodynamics; Hydrochlorothiazide; Male; Nephrectomy; Rats; Rats, Inbred SHR; Renin | 1987 |
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Diabetic Angiopathies; Diabetic Nephropathies; Disease Progression; Diuretics; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Hypertrophy; Kidney; Male; Proteinuria; Rats; Rats, Inbred SHR; Reserpine; Sodium Chloride Symporter Inhibitors | 1999 |